We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EVO market cap is 930.23M. The company's latest EPS is EUR -0.4736 and P/E is -21.71.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 172.2M | 173.88M | 240.69M | 196.28M | 201.31M |
| Operating Income | 55.51M | -17.14M | 32.96M | -11.51M | -25.82M |
| Net Income | -27.94M | -47.28M | -27.2M | -38.95M | -16.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 446.44M | 500.92M | 618.03M | 751.45M | 781.43M |
| Operating Income | 60.38M | 38.09M | 24.43M | 4.89M | -68.26M |
| Net Income | 38.07M | 6.25M | 215.51M | -175.66M | -83.91M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 2.29B | 2.26B | 2.26B | 2.25B | 2.25B |
| Total Liabilities | 1.02B | 1.03B | 1.07B | 1.11B | 1.13B |
| Total Equity | 1.28B | 1.23B | 1.19B | 1.14B | 1.12B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 1.18B | 1.46B | 2.24B | 2.26B | 2.25B |
| Total Liabilities | 703.88M | 740.05M | 857.48M | 1.07B | 1.13B |
| Total Equity | 477.03M | 722.85M | 1.38B | 1.19B | 1.12B |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 240.61M | 236.63M | 203.11M | 15.18M | 36.44M |
| Investing | -206.86M | -435.03M | -415.82M | 13.03M | -13.29M |
| Financing | -45.81M | -50.45M | -52.41M | 53.85M | 71.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 42.22M | 44.72M | 122.24M | 203.11M | 36.44M |
| Investing | -86.63M | -155.09M | -243.86M | -415.82M | -13.29M |
| Financing | 211.26M | 246.41M | 398.43M | -52.41M | 71.96M |
| Market Cap | 930.23M |
| Price to Earnings Ratio | -21.71 |
| Price to Sales Ratio | 2.33 |
| Price to Cash Ratio | 3.57 |
| Price to Book Ratio | 1.63 |
| Dividend Yield | - |
| Shares Outstanding | 177.19M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.2 (3.7%) |
| Company Name | Evotec SE |
| Address |
essener bogen 7 hamburg 22419 |
| Website | https://www.evotec.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
